Clinical Trial Update: Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase III trial evaluating lenalidomide and dexamethasone with or without elotuzumab in newly diagnosed, previously untreated multiple myeloma has completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Elotuzumab (elotuzumab)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2020-10-22